COVID-19: From Bench to Bedside
Editat de Debmalya Barh, Kenneth Lundstromen Limba Engleză Paperback – 4 mar 2022
Key Features
- Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic
- Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 332.17 lei 3-5 săpt. | +23.34 lei 5-11 zile |
| CRC Press – 4 mar 2022 | 332.17 lei 3-5 săpt. | +23.34 lei 5-11 zile |
| Hardback (1) | 1455.48 lei 6-8 săpt. | |
| CRC Press – 4 mar 2022 | 1455.48 lei 6-8 săpt. |
Preț: 332.17 lei
Preț vechi: 349.65 lei
-5% Nou
Puncte Express: 498
Preț estimativ în valută:
63.57€ • 66.23$ • 52.85£
63.57€ • 66.23$ • 52.85£
Carte disponibilă
Livrare economică 20 ianuarie-03 februarie 25
Livrare express 04-10 ianuarie 25 pentru 33.33 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781032040622
ISBN-10: 1032040629
Pagini: 238
Ilustrații: 1 Tables, color; 26 Tables, black and white; 11 Line drawings, color; 19 Halftones, color; 2 Halftones, black and white; 30 Illustrations, color; 2 Illustrations, black and white
Dimensiuni: 178 x 254 x 22 mm
Greutate: 0.44 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
ISBN-10: 1032040629
Pagini: 238
Ilustrații: 1 Tables, color; 26 Tables, black and white; 11 Line drawings, color; 19 Halftones, color; 2 Halftones, black and white; 30 Illustrations, color; 2 Illustrations, black and white
Dimensiuni: 178 x 254 x 22 mm
Greutate: 0.44 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Public țintă
Postgraduate, Professional, and Professional ReferenceCuprins
Chapter 1 Coronavirus epidemics and the current COVID-19 pandemic
Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
Chapter 3 Therapeutic Challenges in COVID-19
Chapter 4 Prevention and Control Strategies for COVID-19 Pandemic
Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their Outcomes
Chapter 6 The evolution of COVID-19 diagnostics
Chapter 7 Drug repurposing and novel antiviral drugs for COVID-19 management
Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19
Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug development
Chapter 12 Nanomaterials in COVID-19 drug development
Chapter 13 Vaccine Development Strategies and the Current Status of COVID-19 Vaccines
Chapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitations
Chapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics
Chapter 2 Biology of Coronaviruses and Predicted Origin of SARS-CoV-2
Chapter 3 Therapeutic Challenges in COVID-19
Chapter 4 Prevention and Control Strategies for COVID-19 Pandemic
Chapter 5 Global Focus and Interdisciplinary Approaches in COVID-19 Research and Their Outcomes
Chapter 6 The evolution of COVID-19 diagnostics
Chapter 7 Drug repurposing and novel antiviral drugs for COVID-19 management
Chapter 8 Convalescent Plasma and Antibody Therapy in COVID-19
Chapter 9 Application Stem Cell and Exosome Based Therapy in COVID-19
Chapter 10 Host and Pathogen-Specific Drug Targets in COVID-19
Chapter 11 Computational biology and bioinformatics in anti-SARS-CoV-2 drug development
Chapter 12 Nanomaterials in COVID-19 drug development
Chapter 13 Vaccine Development Strategies and the Current Status of COVID-19 Vaccines
Chapter 14 Clinical trials of COVID-19 therapeutics and vaccines: history, current status, and limitations
Chapter 15 Lessons Learned from COVID-19 and Their Implementations for Future Pandemics
Notă biografică
Dr. Debmalya Barh is currently a Visiting Full Professor (Titular, Grade-E) at the Department of Genetics, Ecology and Evolution, Institute of Biological Sciences (ICB), Federal University of Minas Gerais (UFMG), Brazil. He is also an honorary Scientist at Institute of Integrative Omics and Applied Biotechnology (IIOAB), India.
Dr. Kenneth Lundstrom is currently the CEO of PanTherapeutics in Lausanne, Switzerland.He serves on editorial boards of various journals including Biomedicines and Viruses, and acts as Editor-in-chief for Frontiers in Translational Virology.
Dr. Kenneth Lundstrom is currently the CEO of PanTherapeutics in Lausanne, Switzerland.He serves on editorial boards of various journals including Biomedicines and Viruses, and acts as Editor-in-chief for Frontiers in Translational Virology.
Descriere
The COVID-19 pandemic has affected the entire world in an unprecedented way and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic.